Adma Biologics, Inc. (ADMA) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 16, 2026.
- Filings shown
- 11
- Open-market buys
- 3
- Open-market sells
- 7
- Buys, 10b5-1 box not checked
- 3 of 3
Counts cover the 11 most recent Form 4 filings Tradune holds for ADMA (filed Mar 17 – Nov 16, 2026); the score below covers only the trailing 90 days (0 buys, 5 sells). SEC EDGAR Form 4 filings for ADMA last checked Nov 21, 2026, 09:00 UTC; the latest ADMA filing Tradune holds was filed Nov 16, 2026. This is not guaranteed to be the complete record — see ADMA's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 3 filings Tradune holds for ADMA filed Nov 5 – Nov 16, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
5 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 4 sales· 168,000 sh
- checkbox disclosed
- On filings with the box not checked
- 1 sale· 10,000 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Adam S. GrossmanPresident and CEO | 0 | 4 | — | 168,000 | −$2,052,120 |
| Lawrence P. GuiheenDirector | 0 | 1 | — | 10,000 | −$139,200 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at ADMA
Insiders reported 3 open-market purchases of ADMA between Mar 17, 2026 and Nov 16, 2026, across 1 distinct buyer. The most recent purchase was reported by Jerrold B. Grossman (Director) on May 27, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Stock Option (Right to Buy) | 10,000 | — | — | — | Nov 16, 2026 |
| Open-market sale 10b5-1 box not checked | 10,000 | $13.92 | 63,599 | −14% | Nov 16, 2026 |
| Option exercise | 10,000 | $5.00 | 73,599 | +16% | Nov 16, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 15,000 | $5.40 | 2,085,777 | +0.7% | Nov 16, 2026 |
| Option exercise Stock Option (Right to Buy) | 15,000 | — | — | — | Nov 16, 2026 |
| Open-market sale 10b5-1 box checked | 6,000 | $13.72 | 2,064,777 | −0.3% | Nov 16, 2026 |
| Open-market sale 10b5-1 box checked | 15,000 | $13.72 | 2,070,777 | −0.7% | Nov 16, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 105,000 | $5.40 | 2,217,777 | +5.0% | Nov 5, 2026 |
| Open-market sale 10b5-1 box checked | 42,000 | $12.00 | 2,070,777 | −2.0% | Nov 5, 2026 |
| Option exercise Stock Option (Right to Buy) | 105,000 | — | — | — | Nov 5, 2026 |
| Open-market sale 10b5-1 box checked | 105,000 | $12.00 | 2,112,777 | −4.7% | Nov 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 3,177 | $8.37 | 443,061 | −0.7% | Jul 24, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 136,363 | — | — | — | Jul 16, 2026 |
| Grant / award | 85,130 | — | 143,149 | +147% | Jul 16, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 6,400 | $7.91 | 520,284 | +1.2% | May 27, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 12,500 | $8.01 | 513,884 | +2.5% | May 12, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 12,500 | $8.01 | 501,384 | +2.6% | May 11, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 20,362 | $9.11 | 446,238 | −4.4% | Apr 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Gift | 30,000 | — | 105,520 | −22% | Mar 17, 2026 |
| Gift | 30,000 | — | 30,000 (indirect) | — | Mar 17, 2026 |
| Option exercise Stock Option (Right to Buy) | 30,000 | — | — | — | Mar 13, 2026 |
| Option exercise | 30,000 | $3.66 | 135,520 | +28% | Mar 13, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 15,000 | $15.16 | 2,118,777 | −0.7% | Mar 16, 2026 |
| Open-market sale 10b5-1 box checked | 6,000 | $15.16 | 2,112,777 | −0.3% | Mar 16, 2026 |
| Option exercise Stock Option (right to buy) | 15,000 | — | — | — | Mar 16, 2026 |
| Option exercise | 15,000 | $5.40 | 2,133,777 | +0.7% | Mar 16, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to ADMA's (Nov 16, 2026).
Frequently asked about ADMA insider activity
How many insiders bought ADMA stock in these Form 4 filings?
1 distinct insider at Adma Biologics, Inc. reported 3 open-market purchases (Form 4 code P) of ADMA shares between Mar 17, 2026 and Nov 16, 2026, the most recent filed by Jerrold B. Grossman (Director) on May 27, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for ADMA?
The most recent Form 4 on this page was filed by Adam S. Grossman (President and CEO) on Nov 16, 2026, reporting 4 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market ADMA insider sale shown?
The largest open-market sale among the filings shown was 105,000 ADMA shares at $12.00 (about $1,260,000) by Adam S. Grossman (President and CEO) on Nov 5, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.
Do the recent ADMA insider purchases have the Form 4 10b5-1 box checked?
No. All 3 ADMA open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Jerrold B. Grossman (Director) on May 27, 2026, 6,400 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for ADMA — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.